The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

  title={The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress},
  author={Carol Y. Francis and J. Morris and P. J. Whorwell},
  journal={Alimentary Pharmacology \& Therapeutics},
BACKGROUND The clinical assessment and investigation of irritable bowel syndrome would be greatly facilitated by the introduction of a simple, easy to use severity scoring system. [] Key MethodRESULTS The maximum achievable score was 500. Mild, moderate and severe cases were indicated by scores of 75 to 175, 175 to 300 and > 300 respectively. Controls scored below 75 and patients scoring in this range can be considered to be in remission.

Irritable bowel syndrome: A comparison of subtypes

A large cohort of patients defined by bowel habit was surveyed to address issues in the relationship between symptom severity and psychological status inIrritable bowel syndrome.

Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation

Historically, measures of symptom severity of irritable bowel syndrome with constipation (IBS‐C) in clinical trials have not met the evidence requirements described in the FDA guidance on

Abdominal distension in health and irritable bowel syndrome: The effect of bladder filling

  • B. IssaJulie MorrisP. Whorwell
  • Medicine
    Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2018
This study tested the hypothesis that bladder filling might trigger an abnormality of the normal accommodation reflex in IBS and found it to be true.

Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients

The prevalence of FI in irritable bowel syndrome (IBS) and its association with clinical, demographic, and pathophysiological factors remain largely unknown.

Practical Evaluation and Handling of Patients with Irritable Bowel Syndrome

The development of the short, self-reported questionnaire, Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS), offers a practical guide to objective measurement of symptoms and effect of given treatments into numerical values in the daily practice.

The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment

The aims of this study were to better define the relationship between irritable bowel syndrome (IBS) and psychiatric disorders and to examine the efficacy of paroxetine in the treatment of IBS

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

Gut‐focused hypnotherapy improves the symptoms of irritable bowel syndrome (IBS) with benefits being sustained for many years and relatively small numbers in published studies.

Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale

This work focuses on the use of pain numeric rating scales (NRS) in IBS clinical trials to measure patient‐reported outcomes in irritable bowel syndrome (IBS) clinical trials effectively.

Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome

Bilvadileha therapy showed statistically significant improvement in all the clinical features of IBS as well as in the IBS severity score.

Quality of life in irritable bowel syndrome: measurement techniques and relevance of current knowledge

  • M. Simrén
  • Medicine
    Expert review of pharmacoeconomics & outcomes research
  • 2003
The concept ofquality of life and instruments used to assess quality of life in irritable bowel syndrome are presented and the current knowledge of quality oflife in irritant bowel syndrome is reviewed, based on existing studies.

The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus

This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion.

Ranking of symptoms by patients with the irritable bowel syndrome.

It is recommended that infusions of large amounts of Gelofusine should be avoided in patients with persistently low renal perfusion pressures or rates of urine flow, as there was clear evidence of severe structural damage to the kidney.

Functional bowel disorders. A multicenter comparison of health status and development of illness severity index.

The FBDSI can be used to select patients for research protocols and/or follow their clinical outcome or response to treatments over time to develop a functional bowel disorder severity index for research and clinical care.

Towards positive diagnosis of the irritable bowel.

The prevention of cot deaths is dependent firstly on the recognition by parents of the significance of certain non-specific symptoms and on their decision to involve the primary care services, and secondly on the efficacy of medical intervention at this stage.

Symptom complaints and health care seeking behavior in subjects with bowel dysfunction.

Although those who consulted physicians for bowel symptoms were more likely to report abdominal pain than those who did not, pain was not sufficient to explain doctor visits and the reported higher prevalence of psychopathology among the patient population with irritable bowel syndrome may be due to behavioral influences that lead to health care seeking.

The Hospital Anxiety and Depression Scale.

  • G. Huston
  • Psychology
    The Journal of rheumatology
  • 1987